T-cell engaging chimeric antibody 5T4/CD3 (Sutro Biopharma)

N/A

Report date: 2026/03/19 16:53:38

Base Information

Drug NameT-cell engaging chimeric antibody 5T4/CD3 (Sutro Biopharma)
Drug Alias Nameanti-CD3/anti-5T4 T-cell engager (Sutro Biopharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsTrophoblast glycoprotein modulators
TargetsT cell surface glycoprotein CD3Trophoblast glycoprotein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSutro Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSutro Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A